Arch Therapeutics hits its $2.9 million funding goal after announcing a private stock placement late last year.
Arch Therapeutics hit its nearly $2.9 million target with a private placement announced late last year.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1bPmlqS
Cap comentari:
Publica un comentari a l'entrada